| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 166 | 2023 | 5767 | 8.420 |
Why?
|
| Prostate | 53 | 2022 | 1088 | 5.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 71 | 2023 | 8873 | 2.840 |
Why?
|
| Fibroblast Growth Factors | 17 | 2017 | 257 | 2.690 |
Why?
|
| Prostatic Hyperplasia | 18 | 2016 | 210 | 2.570 |
Why?
|
| Receptors, Fibroblast Growth Factor | 16 | 2021 | 153 | 1.890 |
Why?
|
| Receptors, Androgen | 29 | 2022 | 878 | 1.700 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 7 | 2016 | 27 | 1.480 |
Why?
|
| Oncogene Proteins, Fusion | 6 | 2020 | 755 | 1.470 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 11 | 2017 | 182 | 1.430 |
Why?
|
| Cell Line, Tumor | 78 | 2023 | 14551 | 1.390 |
Why?
|
| Phosphoric Monoester Hydrolases | 9 | 2021 | 243 | 1.360 |
Why?
|
| Genes, Tumor Suppressor | 11 | 2017 | 1064 | 1.350 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 1143 | 1.250 |
Why?
|
| Cell Proliferation | 47 | 2023 | 7226 | 1.180 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2021 | 2054 | 1.180 |
Why?
|
| Male | 219 | 2024 | 123000 | 1.180 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 7 | 2024 | 425 | 1.160 |
Why?
|
| DNA Methylation | 19 | 2023 | 2669 | 1.150 |
Why?
|
| Fibroblast Growth Factor 2 | 8 | 2008 | 223 | 1.150 |
Why?
|
| Mice | 103 | 2024 | 34495 | 1.010 |
Why?
|
| Signal Transduction | 45 | 2021 | 11965 | 1.000 |
Why?
|
| PTEN Phosphohydrolase | 21 | 2021 | 986 | 1.000 |
Why?
|
| MicroRNAs | 17 | 2021 | 2947 | 0.980 |
Why?
|
| Animals | 126 | 2024 | 59536 | 0.970 |
Why?
|
| Transcription Factors | 18 | 2020 | 5270 | 0.960 |
Why?
|
| Serine Endopeptidases | 6 | 2020 | 275 | 0.940 |
Why?
|
| RNA, Small Interfering | 8 | 2019 | 2216 | 0.920 |
Why?
|
| Carcinogenesis | 9 | 2023 | 1026 | 0.920 |
Why?
|
| RNA, Messenger | 24 | 2023 | 6150 | 0.910 |
Why?
|
| Epithelial Cells | 24 | 2022 | 1818 | 0.900 |
Why?
|
| Stromal Cells | 20 | 2019 | 825 | 0.900 |
Why?
|
| Biomarkers, Tumor | 30 | 2022 | 10331 | 0.830 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 12 | 2017 | 84 | 0.820 |
Why?
|
| Gene Expression Profiling | 23 | 2018 | 5159 | 0.810 |
Why?
|
| Humans | 229 | 2024 | 261506 | 0.790 |
Why?
|
| Neoplasm Proteins | 16 | 2019 | 3230 | 0.770 |
Why?
|
| Mice, SCID | 19 | 2023 | 1869 | 0.770 |
Why?
|
| Genes | 6 | 2010 | 491 | 0.770 |
Why?
|
| Transfection | 20 | 2017 | 2944 | 0.730 |
Why?
|
| Transcriptional Regulator ERG | 9 | 2020 | 61 | 0.730 |
Why?
|
| Adenocarcinoma | 22 | 2022 | 7789 | 0.700 |
Why?
|
| Epithelium | 6 | 2023 | 720 | 0.690 |
Why?
|
| Mice, Transgenic | 32 | 2022 | 4143 | 0.660 |
Why?
|
| Chromosomes, Human, Pair 10 | 6 | 1998 | 135 | 0.660 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2017 | 460 | 0.650 |
Why?
|
| Disease Progression | 30 | 2019 | 6682 | 0.640 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 26 | 2015 | 3639 | 0.630 |
Why?
|
| RNA Interference | 8 | 2017 | 1408 | 0.610 |
Why?
|
| SOXB1 Transcription Factors | 4 | 2021 | 123 | 0.610 |
Why?
|
| Oncogene Protein v-akt | 1 | 2017 | 101 | 0.600 |
Why?
|
| Gene Knockdown Techniques | 9 | 2019 | 1077 | 0.590 |
Why?
|
| RGS Proteins | 1 | 2017 | 61 | 0.590 |
Why?
|
| Growth Substances | 5 | 2001 | 300 | 0.590 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2019 | 476 | 0.590 |
Why?
|
| Immunohistochemistry | 27 | 2020 | 7548 | 0.580 |
Why?
|
| Up-Regulation | 20 | 2022 | 2450 | 0.580 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2019 | 1823 | 0.560 |
Why?
|
| Membrane Proteins | 13 | 2013 | 2819 | 0.550 |
Why?
|
| Oncogenes | 3 | 2016 | 673 | 0.550 |
Why?
|
| Anti-HIV Agents | 3 | 2023 | 350 | 0.550 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2021 | 1678 | 0.540 |
Why?
|
| Tissue Array Analysis | 9 | 2019 | 760 | 0.540 |
Why?
|
| Deoxyguanosine | 1 | 2015 | 37 | 0.540 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 984 | 0.530 |
Why?
|
| Cellular Senescence | 4 | 2014 | 382 | 0.530 |
Why?
|
| Alternative Splicing | 5 | 2011 | 584 | 0.510 |
Why?
|
| Disease Models, Animal | 20 | 2022 | 7222 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 370 | 0.500 |
Why?
|
| RANK Ligand | 3 | 2022 | 119 | 0.500 |
Why?
|
| Tumor Microenvironment | 11 | 2024 | 2864 | 0.490 |
Why?
|
| Phosphoproteins | 5 | 2012 | 1152 | 0.490 |
Why?
|
| GTPase-Activating Proteins | 2 | 2012 | 126 | 0.480 |
Why?
|
| Benzamides | 4 | 2021 | 1832 | 0.480 |
Why?
|
| Interleukin-8 | 3 | 2014 | 519 | 0.470 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2014 | 35 | 0.470 |
Why?
|
| Gene Fusion | 5 | 2020 | 209 | 0.470 |
Why?
|
| GTP-Binding Proteins | 3 | 2012 | 321 | 0.470 |
Why?
|
| Prostate-Specific Antigen | 15 | 2022 | 993 | 0.440 |
Why?
|
| Cell Division | 16 | 2007 | 2489 | 0.440 |
Why?
|
| Pyrroles | 1 | 2017 | 576 | 0.440 |
Why?
|
| Cell Movement | 14 | 2018 | 2466 | 0.430 |
Why?
|
| Blotting, Western | 14 | 2016 | 3536 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 18 | 2021 | 5395 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 14 | 2018 | 2508 | 0.420 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2021 | 2488 | 0.410 |
Why?
|
| Neoplasm Metastasis | 17 | 2020 | 5112 | 0.400 |
Why?
|
| Neoplasm Transplantation | 10 | 2018 | 1519 | 0.400 |
Why?
|
| Tumor Burden | 6 | 2017 | 1987 | 0.400 |
Why?
|
| Paracrine Communication | 3 | 2001 | 128 | 0.400 |
Why?
|
| Serum Response Factor | 1 | 2011 | 51 | 0.400 |
Why?
|
| Alleles | 7 | 2011 | 2437 | 0.390 |
Why?
|
| Trans-Activators | 8 | 2015 | 1555 | 0.390 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2015 | 1489 | 0.390 |
Why?
|
| Receptors, G-Protein-Coupled | 8 | 2010 | 488 | 0.380 |
Why?
|
| DNA-Binding Proteins | 8 | 2020 | 4821 | 0.380 |
Why?
|
| CpG Islands | 8 | 2023 | 633 | 0.380 |
Why?
|
| Stem Cells | 7 | 2019 | 1213 | 0.380 |
Why?
|
| RNA, Neoplasm | 5 | 2018 | 771 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 1443 | 0.370 |
Why?
|
| DNA Mutational Analysis | 4 | 2017 | 2283 | 0.370 |
Why?
|
| Transforming Growth Factor beta | 7 | 2019 | 1130 | 0.360 |
Why?
|
| Nerve Tissue Proteins | 7 | 2023 | 1491 | 0.360 |
Why?
|
| Mice, Nude | 15 | 2016 | 4307 | 0.360 |
Why?
|
| Prostatectomy | 13 | 2022 | 962 | 0.350 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2022 | 2359 | 0.350 |
Why?
|
| NF-kappa B | 7 | 2022 | 1549 | 0.350 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 203 | 0.340 |
Why?
|
| Pyrazoles | 2 | 2021 | 1471 | 0.340 |
Why?
|
| Piperazines | 2 | 2021 | 2101 | 0.340 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2004 | 661 | 0.340 |
Why?
|
| Apoptosis | 27 | 2021 | 7591 | 0.340 |
Why?
|
| Neoplasm Recurrence, Local | 16 | 2022 | 10035 | 0.330 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2021 | 973 | 0.330 |
Why?
|
| Androgens | 7 | 2016 | 511 | 0.320 |
Why?
|
| Laryngeal Neoplasms | 3 | 2016 | 518 | 0.310 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2021 | 3821 | 0.300 |
Why?
|
| Neovascularization, Pathologic | 6 | 2018 | 1547 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 18 | 2019 | 6942 | 0.300 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 3 | 2024 | 59 | 0.300 |
Why?
|
| Protein Isoforms | 5 | 2012 | 842 | 0.300 |
Why?
|
| Cell Cycle Proteins | 5 | 2016 | 2045 | 0.300 |
Why?
|
| Heterografts | 4 | 2018 | 733 | 0.300 |
Why?
|
| Dinucleoside Phosphates | 1 | 2006 | 19 | 0.290 |
Why?
|
| HIV Infections | 3 | 2023 | 2134 | 0.290 |
Why?
|
| Racemases and Epimerases | 1 | 2006 | 16 | 0.280 |
Why?
|
| Polymerase Chain Reaction | 10 | 2015 | 3203 | 0.280 |
Why?
|
| Transcriptome | 5 | 2023 | 1859 | 0.280 |
Why?
|
| Receptors, Odorant | 1 | 2006 | 47 | 0.280 |
Why?
|
| Glucuronidase | 3 | 2018 | 48 | 0.280 |
Why?
|
| Mutation, Missense | 1 | 2012 | 1152 | 0.280 |
Why?
|
| Carcinoma | 5 | 2010 | 2578 | 0.280 |
Why?
|
| Nuclear Proteins | 6 | 2017 | 3343 | 0.280 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2021 | 2341 | 0.280 |
Why?
|
| Cytokines | 2 | 2022 | 2809 | 0.280 |
Why?
|
| Carrier Proteins | 5 | 2023 | 2022 | 0.270 |
Why?
|
| Genes, Dominant | 2 | 2004 | 331 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2017 | 810 | 0.270 |
Why?
|
| RNA Polymerase III | 3 | 1995 | 49 | 0.270 |
Why?
|
| Transcription, Genetic | 9 | 2019 | 3154 | 0.260 |
Why?
|
| Homozygote | 3 | 2009 | 717 | 0.260 |
Why?
|
| Phosphorylation | 9 | 2021 | 4804 | 0.260 |
Why?
|
| cdc25 Phosphatases | 1 | 2005 | 97 | 0.260 |
Why?
|
| Cell Differentiation | 13 | 2023 | 4078 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 11 | 2018 | 3981 | 0.250 |
Why?
|
| Cell Cycle | 9 | 2014 | 2084 | 0.250 |
Why?
|
| Down-Regulation | 10 | 2015 | 2074 | 0.250 |
Why?
|
| Real-Time Polymerase Chain Reaction | 7 | 2020 | 1217 | 0.250 |
Why?
|
| Androgen Antagonists | 6 | 2018 | 411 | 0.250 |
Why?
|
| Liposomes | 2 | 2019 | 684 | 0.250 |
Why?
|
| Mice, Inbred NOD | 8 | 2023 | 905 | 0.240 |
Why?
|
| Cytoskeletal Proteins | 1 | 2006 | 492 | 0.240 |
Why?
|
| Pyrimidines | 1 | 2017 | 3518 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2023 | 5437 | 0.240 |
Why?
|
| Mice, Knockout | 15 | 2021 | 5710 | 0.240 |
Why?
|
| Protein Kinases | 3 | 2022 | 874 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 11 | 2019 | 3101 | 0.240 |
Why?
|
| Dioxins | 1 | 2023 | 3 | 0.240 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2023 | 13 | 0.230 |
Why?
|
| COUP Transcription Factor II | 2 | 2016 | 126 | 0.230 |
Why?
|
| In Situ Hybridization | 9 | 2015 | 1037 | 0.230 |
Why?
|
| Wnt Signaling Pathway | 3 | 2019 | 430 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2015 | 299 | 0.230 |
Why?
|
| Neoplasms | 9 | 2023 | 15193 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 8 | 2013 | 2483 | 0.230 |
Why?
|
| Genetic Variation | 4 | 2018 | 2086 | 0.230 |
Why?
|
| Genetic Therapy | 3 | 2011 | 1616 | 0.230 |
Why?
|
| Gene Expression | 6 | 2016 | 3570 | 0.230 |
Why?
|
| Cells, Cultured | 10 | 2019 | 5637 | 0.230 |
Why?
|
| Gene Expression Regulation | 11 | 2016 | 4053 | 0.230 |
Why?
|
| Mitochondria | 3 | 2019 | 1282 | 0.220 |
Why?
|
| Interleukin-1 | 2 | 2003 | 461 | 0.220 |
Why?
|
| Salivary Gland Neoplasms | 2 | 2019 | 489 | 0.220 |
Why?
|
| Ubiquitination | 4 | 2021 | 575 | 0.220 |
Why?
|
| Smad Proteins | 1 | 2023 | 88 | 0.220 |
Why?
|
| DNA Adducts | 1 | 2023 | 210 | 0.220 |
Why?
|
| Wnt Proteins | 3 | 2013 | 397 | 0.210 |
Why?
|
| Mutation | 14 | 2017 | 15179 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 5539 | 0.210 |
Why?
|
| Receptors, Notch | 3 | 2016 | 383 | 0.210 |
Why?
|
| Adenoviridae | 3 | 2011 | 1459 | 0.210 |
Why?
|
| Gene Deletion | 4 | 2012 | 1442 | 0.210 |
Why?
|
| Fibroblasts | 6 | 2014 | 1682 | 0.210 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 8 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 4 | 2021 | 848 | 0.210 |
Why?
|
| Cell Survival | 11 | 2016 | 3045 | 0.210 |
Why?
|
| Homeostasis | 3 | 2023 | 950 | 0.210 |
Why?
|
| Doxycycline | 1 | 2022 | 178 | 0.200 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2017 | 1546 | 0.200 |
Why?
|
| Microsatellite Repeats | 4 | 2016 | 575 | 0.200 |
Why?
|
| Autophagy-Related Protein-1 Homolog | 1 | 2021 | 10 | 0.200 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2019 | 73 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 4757 | 0.200 |
Why?
|
| Tissue Kallikreins | 1 | 2020 | 8 | 0.200 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2021 | 89 | 0.200 |
Why?
|
| DNA, Neoplasm | 4 | 2020 | 1910 | 0.190 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2020 | 1105 | 0.190 |
Why?
|
| Fibroblast Growth Factor 7 | 4 | 2003 | 30 | 0.190 |
Why?
|
| Protective Agents | 1 | 2021 | 51 | 0.190 |
Why?
|
| Nuclear Receptor Coactivator 3 | 6 | 2017 | 383 | 0.190 |
Why?
|
| Cell Line | 7 | 2017 | 5114 | 0.190 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2022 | 46 | 0.190 |
Why?
|
| Neoplasm Grading | 4 | 2019 | 1742 | 0.190 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 1998 | 182 | 0.190 |
Why?
|
| RNA Helicases | 1 | 2021 | 101 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1997 | 141 | 0.180 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 854 | 0.180 |
Why?
|
| Gene Silencing | 5 | 2016 | 837 | 0.180 |
Why?
|
| Fibroblast Growth Factor 10 | 4 | 2000 | 26 | 0.180 |
Why?
|
| Pseudogenes | 1 | 2000 | 81 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 255 | 0.180 |
Why?
|
| Middle Aged | 35 | 2020 | 86204 | 0.180 |
Why?
|
| Genomics | 4 | 2022 | 2738 | 0.180 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2016 | 716 | 0.180 |
Why?
|
| DNA, Mitochondrial | 2 | 2016 | 311 | 0.180 |
Why?
|
| Inactivation, Metabolic | 1 | 2019 | 37 | 0.180 |
Why?
|
| Nuclear Receptor Coactivator 2 | 2 | 2015 | 210 | 0.180 |
Why?
|
| Random Allocation | 2 | 2019 | 703 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 3 | 2011 | 246 | 0.180 |
Why?
|
| CD8 Antigens | 1 | 2020 | 170 | 0.180 |
Why?
|
| Genes, Retinoblastoma | 2 | 1997 | 86 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2019 | 48 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2019 | 33 | 0.170 |
Why?
|
| Papillomaviridae | 2 | 2020 | 624 | 0.170 |
Why?
|
| Autocrine Communication | 1 | 1999 | 84 | 0.170 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 45 | 0.170 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2018 | 194 | 0.170 |
Why?
|
| Endometrium | 1 | 2023 | 470 | 0.170 |
Why?
|
| Interleukin-6 | 2 | 2014 | 1038 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2017 | 1664 | 0.170 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 347 | 0.170 |
Why?
|
| Neurogenesis | 2 | 2013 | 238 | 0.170 |
Why?
|
| Salivary Glands | 1 | 2019 | 130 | 0.170 |
Why?
|
| HEK293 Cells | 3 | 2021 | 1489 | 0.170 |
Why?
|
| Cell Adhesion | 3 | 2013 | 1008 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2017 | 96 | 0.170 |
Why?
|
| Databases, Nucleic Acid | 1 | 2019 | 117 | 0.160 |
Why?
|
| Relaxin | 2 | 2009 | 21 | 0.160 |
Why?
|
| Histone Acetyltransferases | 4 | 2008 | 411 | 0.160 |
Why?
|
| Phenotype | 7 | 2023 | 6295 | 0.160 |
Why?
|
| Receptor, trkA | 1 | 2018 | 35 | 0.160 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2018 | 23 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 778 | 0.160 |
Why?
|
| Molecular Sequence Data | 12 | 2016 | 6089 | 0.160 |
Why?
|
| Toxicity Tests | 1 | 2018 | 50 | 0.160 |
Why?
|
| Uterus | 1 | 2023 | 678 | 0.160 |
Why?
|
| Tumor Escape | 1 | 2020 | 251 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 3976 | 0.160 |
Why?
|
| Cluster Analysis | 4 | 2017 | 1053 | 0.160 |
Why?
|
| Denervation | 1 | 2017 | 33 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 622 | 0.150 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 598 | 0.150 |
Why?
|
| Transplantation, Heterologous | 5 | 2013 | 1082 | 0.150 |
Why?
|
| Blotting, Southern | 4 | 2000 | 406 | 0.150 |
Why?
|
| Inflammation | 5 | 2016 | 2522 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 353 | 0.150 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2017 | 221 | 0.150 |
Why?
|
| Multigene Family | 2 | 2017 | 425 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 1265 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 133 | 0.150 |
Why?
|
| Caveolins | 3 | 2002 | 73 | 0.150 |
Why?
|
| Retroviridae | 2 | 2017 | 332 | 0.150 |
Why?
|
| Proteoglycans | 3 | 2015 | 259 | 0.150 |
Why?
|
| Base Sequence | 11 | 2016 | 4917 | 0.150 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 42 | 0.150 |
Why?
|
| CELF1 Protein | 1 | 2016 | 46 | 0.150 |
Why?
|
| G-Protein-Coupled Receptor Kinase 3 | 1 | 2016 | 14 | 0.150 |
Why?
|
| Kidney Pelvis | 1 | 2017 | 102 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 32 | 0.140 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 19 | 0.140 |
Why?
|
| Genetic Engineering | 3 | 2016 | 288 | 0.140 |
Why?
|
| Neoplasms, Hormone-Dependent | 3 | 2007 | 342 | 0.140 |
Why?
|
| Proteogenomics | 1 | 2017 | 87 | 0.140 |
Why?
|
| Hexosamines | 1 | 2016 | 25 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2022 | 731 | 0.140 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 554 | 0.140 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 101 | 0.140 |
Why?
|
| Semaphorins | 2 | 2013 | 38 | 0.140 |
Why?
|
| Ligands | 3 | 2022 | 995 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 4938 | 0.140 |
Why?
|
| Female | 36 | 2023 | 141928 | 0.140 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2016 | 239 | 0.140 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2016 | 71 | 0.140 |
Why?
|
| NADPH Oxidase 4 | 1 | 2015 | 23 | 0.140 |
Why?
|
| Receptors, Calcitriol | 2 | 2014 | 134 | 0.140 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2016 | 113 | 0.140 |
Why?
|
| Collagen Type I | 1 | 2016 | 204 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2330 | 0.140 |
Why?
|
| Time Factors | 10 | 2016 | 12926 | 0.140 |
Why?
|
| Aged | 28 | 2020 | 70117 | 0.130 |
Why?
|
| Models, Biological | 3 | 2016 | 3254 | 0.130 |
Why?
|
| Interphase | 2 | 1993 | 145 | 0.130 |
Why?
|
| Camptothecin | 1 | 2018 | 517 | 0.130 |
Why?
|
| Neoplasms, Experimental | 4 | 2016 | 750 | 0.130 |
Why?
|
| Urothelium | 1 | 2017 | 254 | 0.130 |
Why?
|
| Cell Transdifferentiation | 1 | 2016 | 112 | 0.130 |
Why?
|
| Models, Animal | 1 | 2018 | 664 | 0.130 |
Why?
|
| Comparative Genomic Hybridization | 3 | 2016 | 691 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 598 | 0.130 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 5 | 2003 | 96 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2009 | 1756 | 0.130 |
Why?
|
| Ureter | 1 | 2017 | 209 | 0.130 |
Why?
|
| Prognosis | 14 | 2022 | 21713 | 0.130 |
Why?
|
| Urologic Neoplasms | 1 | 2017 | 188 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 129 | 0.130 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2019 | 413 | 0.130 |
Why?
|
| Ureteral Neoplasms | 1 | 2017 | 228 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5178 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 15862 | 0.130 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 1450 | 0.130 |
Why?
|
| NADPH Oxidases | 1 | 2015 | 146 | 0.130 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 138 | 0.130 |
Why?
|
| Ribonuclease III | 2 | 2013 | 182 | 0.130 |
Why?
|
| Gene Targeting | 1 | 2016 | 292 | 0.130 |
Why?
|
| Genome, Human | 2 | 2015 | 1869 | 0.130 |
Why?
|
| Nanoparticles | 1 | 2019 | 554 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 218 | 0.130 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2017 | 185 | 0.130 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2014 | 37 | 0.130 |
Why?
|
| Steroid Hydroxylases | 1 | 2014 | 36 | 0.120 |
Why?
|
| Chromosomes, Human | 1 | 2016 | 295 | 0.120 |
Why?
|
| Benzylamines | 1 | 2014 | 105 | 0.120 |
Why?
|
| GATA2 Transcription Factor | 1 | 2014 | 68 | 0.120 |
Why?
|
| DNA Copy Number Variations | 2 | 2011 | 1516 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 2 | 2017 | 1121 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 184 | 0.120 |
Why?
|
| B7-H1 Antigen | 1 | 2021 | 1022 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 362 | 0.120 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 76 | 0.120 |
Why?
|
| Cathepsin D | 1 | 2014 | 32 | 0.120 |
Why?
|
| Lung Neoplasms | 5 | 2022 | 11538 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2015 | 445 | 0.120 |
Why?
|
| Prostatitis | 1 | 2013 | 18 | 0.120 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 38 | 0.120 |
Why?
|
| Phosphorylcholine | 2 | 2011 | 54 | 0.120 |
Why?
|
| Neuroepithelial Cells | 1 | 2013 | 13 | 0.120 |
Why?
|
| Microfilament Proteins | 2 | 2016 | 487 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 335 | 0.120 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2013 | 33 | 0.120 |
Why?
|
| Acetyltransferases | 2 | 2023 | 143 | 0.120 |
Why?
|
| Testosterone | 4 | 2011 | 619 | 0.120 |
Why?
|
| Neurons | 3 | 2016 | 2287 | 0.120 |
Why?
|
| Mannosidases | 1 | 2013 | 19 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2015 | 249 | 0.120 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2013 | 8 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 362 | 0.120 |
Why?
|
| Benzoates | 1 | 2014 | 136 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 229 | 0.110 |
Why?
|
| Sulfotransferases | 1 | 2013 | 36 | 0.110 |
Why?
|
| In Vitro Techniques | 3 | 2012 | 1618 | 0.110 |
Why?
|
| New York | 1 | 2013 | 104 | 0.110 |
Why?
|
| HSC70 Heat-Shock Proteins | 1 | 2012 | 14 | 0.110 |
Why?
|
| Exons | 5 | 2008 | 1328 | 0.110 |
Why?
|
| Interleukin-4 | 1 | 2014 | 284 | 0.110 |
Why?
|
| T-Lymphocytes | 3 | 2015 | 3869 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1996 | 641 | 0.110 |
Why?
|
| Lipoproteins, VLDL | 2 | 1983 | 89 | 0.110 |
Why?
|
| Neuroblastoma | 2 | 2016 | 686 | 0.110 |
Why?
|
| Chromosome Mapping | 6 | 2006 | 1471 | 0.110 |
Why?
|
| Rats | 6 | 2023 | 6086 | 0.110 |
Why?
|
| Microbiological Techniques | 1 | 2012 | 40 | 0.110 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 3022 | 0.110 |
Why?
|
| Mouth Diseases | 1 | 1992 | 34 | 0.110 |
Why?
|
| DNA Damage | 2 | 2023 | 1954 | 0.110 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2010 | 69 | 0.110 |
Why?
|
| Antigens, CD34 | 1 | 2014 | 593 | 0.110 |
Why?
|
| CDC2 Protein Kinase | 2 | 2004 | 176 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.110 |
Why?
|
| Urine | 1 | 2012 | 143 | 0.110 |
Why?
|
| Vasculitis | 1 | 1992 | 61 | 0.110 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 1960 | 0.110 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 408 | 0.110 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2012 | 20 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2018 | 634 | 0.100 |
Why?
|
| Vitamin D | 1 | 2014 | 261 | 0.100 |
Why?
|
| Genes, Suppressor | 1 | 2011 | 25 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2005 | 614 | 0.100 |
Why?
|
| Receptors, Peptide | 2 | 2009 | 86 | 0.100 |
Why?
|
| Peripheral Nerves | 3 | 2008 | 159 | 0.100 |
Why?
|
| Carcinoma, Papillary | 1 | 2015 | 584 | 0.100 |
Why?
|
| Neoplasm Staging | 9 | 2012 | 13658 | 0.100 |
Why?
|
| Aurora Kinase A | 1 | 2012 | 202 | 0.100 |
Why?
|
| Chordoma | 1 | 2013 | 163 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2010 | 292 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 479 | 0.100 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2086 | 0.100 |
Why?
|
| Chromosome Deletion | 1 | 1996 | 1005 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2019 | 6100 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 446 | 0.100 |
Why?
|
| Chromosome Breakpoints | 1 | 2011 | 104 | 0.100 |
Why?
|
| Caveolin 1 | 4 | 2006 | 204 | 0.100 |
Why?
|
| Orchiectomy | 5 | 2013 | 214 | 0.100 |
Why?
|
| Ganglia | 1 | 2010 | 20 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2023 | 717 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2019 | 980 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2012 | 240 | 0.100 |
Why?
|
| Oxidative Stress | 2 | 2015 | 1129 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 11 | 0.100 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2010 | 27 | 0.100 |
Why?
|
| Arachidonic Acid | 1 | 2011 | 118 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 4 | 2016 | 5061 | 0.090 |
Why?
|
| Loss of Heterozygosity | 4 | 2004 | 602 | 0.090 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 14289 | 0.090 |
Why?
|
| Osteonectin | 1 | 2010 | 53 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 4549 | 0.090 |
Why?
|
| Genotype | 5 | 2016 | 4109 | 0.090 |
Why?
|
| Androgen-Binding Protein | 2 | 2007 | 39 | 0.090 |
Why?
|
| COS Cells | 1 | 2010 | 377 | 0.090 |
Why?
|
| Aging | 2 | 2010 | 1582 | 0.090 |
Why?
|
| Health | 1 | 2010 | 54 | 0.090 |
Why?
|
| Diet | 1 | 2018 | 1440 | 0.090 |
Why?
|
| Mitogens | 2 | 2000 | 75 | 0.090 |
Why?
|
| Transgenes | 3 | 2007 | 557 | 0.090 |
Why?
|
| Macrophages | 1 | 2016 | 1304 | 0.090 |
Why?
|
| Proteomics | 1 | 2017 | 1380 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2016 | 3552 | 0.090 |
Why?
|
| Dihydrotestosterone | 2 | 2007 | 118 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 534 | 0.090 |
Why?
|
| Lipid Metabolism | 2 | 2024 | 483 | 0.090 |
Why?
|
| Endoribonucleases | 1 | 2010 | 107 | 0.090 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 314 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2011 | 829 | 0.090 |
Why?
|
| Recurrence | 4 | 2016 | 4758 | 0.090 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2009 | 54 | 0.090 |
Why?
|
| Endopeptidases | 1 | 2010 | 220 | 0.080 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2010 | 365 | 0.080 |
Why?
|
| Consensus | 1 | 2013 | 978 | 0.080 |
Why?
|
| CDC28 Protein Kinase, S cerevisiae | 1 | 2008 | 3 | 0.080 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 29902 | 0.080 |
Why?
|
| Flow Cytometry | 4 | 2015 | 3033 | 0.080 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2011 | 363 | 0.080 |
Why?
|
| Nitriles | 4 | 2016 | 906 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 2009 | 137 | 0.080 |
Why?
|
| Ki-67 Antigen | 3 | 2006 | 666 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2015 | 1146 | 0.080 |
Why?
|
| HeLa Cells | 5 | 2015 | 1643 | 0.080 |
Why?
|
| Biopsy, Needle | 2 | 2006 | 1363 | 0.080 |
Why?
|
| Focal Adhesions | 1 | 2008 | 45 | 0.080 |
Why?
|
| Survival Analysis | 4 | 2017 | 9180 | 0.080 |
Why?
|
| Ganglia, Spinal | 2 | 2006 | 237 | 0.080 |
Why?
|
| Veterans | 1 | 2019 | 1641 | 0.080 |
Why?
|
| Amino Acid Sequence | 8 | 2012 | 4233 | 0.080 |
Why?
|
| Melanoma | 2 | 2013 | 5317 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2012 | 321 | 0.080 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 139 | 0.080 |
Why?
|
| Breast Neoplasms | 8 | 2017 | 15694 | 0.080 |
Why?
|
| Antibodies | 4 | 2013 | 838 | 0.080 |
Why?
|
| Heterozygote | 3 | 1996 | 1020 | 0.080 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2008 | 129 | 0.080 |
Why?
|
| Azasteroids | 1 | 2007 | 11 | 0.080 |
Why?
|
| Tumor Virus Infections | 1 | 2009 | 224 | 0.080 |
Why?
|
| Databases, Genetic | 3 | 2017 | 745 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8865 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 143 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2007 | 47 | 0.080 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2007 | 20 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 2291 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2006 | 1555 | 0.080 |
Why?
|
| Receptors, Neuropeptide | 1 | 2007 | 27 | 0.080 |
Why?
|
| Epigenomics | 2 | 2023 | 266 | 0.080 |
Why?
|
| Cancer Vaccines | 1 | 2013 | 697 | 0.080 |
Why?
|
| DNA | 5 | 2006 | 2693 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 4654 | 0.070 |
Why?
|
| beta Catenin | 3 | 2019 | 688 | 0.070 |
Why?
|
| Microspheres | 1 | 2007 | 210 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2008 | 869 | 0.070 |
Why?
|
| Adipocytes, Brown | 1 | 2007 | 32 | 0.070 |
Why?
|
| Peptides | 1 | 2013 | 1479 | 0.070 |
Why?
|
| Metribolone | 3 | 2013 | 48 | 0.070 |
Why?
|
| Cartilage | 1 | 2007 | 128 | 0.070 |
Why?
|
| Prostatic Diseases | 1 | 2006 | 30 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2019 | 6869 | 0.070 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2008 | 311 | 0.070 |
Why?
|
| Chondrogenesis | 1 | 2007 | 67 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2008 | 362 | 0.070 |
Why?
|
| Somatomedins | 1 | 2006 | 75 | 0.070 |
Why?
|
| Neurites | 1 | 2006 | 63 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2013 | 1335 | 0.070 |
Why?
|
| Sequence Deletion | 3 | 2017 | 875 | 0.070 |
Why?
|
| Chondrocytes | 1 | 2007 | 107 | 0.070 |
Why?
|
| Estrenes | 1 | 2006 | 24 | 0.070 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 79 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2003 | 110 | 0.070 |
Why?
|
| Wound Healing | 2 | 2004 | 815 | 0.070 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1506 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 394 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 3 | 2013 | 1165 | 0.070 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 709 | 0.070 |
Why?
|
| Risk | 3 | 2020 | 1972 | 0.070 |
Why?
|
| DNA Repair | 2 | 2023 | 1872 | 0.070 |
Why?
|
| Protein Binding | 4 | 2018 | 3438 | 0.070 |
Why?
|
| Genomic Instability | 2 | 2021 | 519 | 0.070 |
Why?
|
| Smad4 Protein | 2 | 2020 | 196 | 0.070 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 1399 | 0.070 |
Why?
|
| Pyrazines | 1 | 2008 | 495 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 5 | 2016 | 2314 | 0.070 |
Why?
|
| Mesoderm | 1 | 2007 | 404 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2016 | 65 | 0.070 |
Why?
|
| Osteogenesis | 1 | 2007 | 271 | 0.070 |
Why?
|
| Cell Death | 2 | 2012 | 671 | 0.070 |
Why?
|
| F-Box Proteins | 1 | 2006 | 96 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 246 | 0.070 |
Why?
|
| Survival Rate | 4 | 2021 | 12221 | 0.070 |
Why?
|
| Glutamine | 2 | 2018 | 299 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2018 | 9244 | 0.060 |
Why?
|
| Herpesvirus 4, Human | 1 | 2009 | 966 | 0.060 |
Why?
|
| Phenylthiohydantoin | 2 | 2016 | 89 | 0.060 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2009 | 489 | 0.060 |
Why?
|
| Base Pair Mismatch | 1 | 2004 | 78 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 2927 | 0.060 |
Why?
|
| Liver | 3 | 2002 | 2961 | 0.060 |
Why?
|
| Muscle, Skeletal | 3 | 2007 | 1270 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2009 | 1113 | 0.060 |
Why?
|
| Adult | 15 | 2019 | 77950 | 0.060 |
Why?
|
| Proportional Hazards Models | 4 | 2016 | 4988 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 4971 | 0.060 |
Why?
|
| Seminal Vesicles | 3 | 2013 | 152 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2004 | 107 | 0.060 |
Why?
|
| Gene Rearrangement | 2 | 2020 | 783 | 0.060 |
Why?
|
| Laminin | 1 | 2004 | 194 | 0.060 |
Why?
|
| Hep G2 Cells | 2 | 2015 | 155 | 0.060 |
Why?
|
| Plasmids | 3 | 2004 | 837 | 0.060 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2003 | 20 | 0.060 |
Why?
|
| Deoxyadenosines | 1 | 2023 | 42 | 0.060 |
Why?
|
| Genetic Vectors | 3 | 2011 | 1694 | 0.060 |
Why?
|
| Macaca | 1 | 2023 | 95 | 0.060 |
Why?
|
| Enzyme Activation | 4 | 2009 | 1764 | 0.060 |
Why?
|
| Lipolysis | 1 | 2024 | 108 | 0.060 |
Why?
|
| Lipase | 1 | 2024 | 112 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 354 | 0.060 |
Why?
|
| Coculture Techniques | 3 | 2013 | 626 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2003 | 151 | 0.060 |
Why?
|
| Tenofovir | 1 | 2023 | 23 | 0.060 |
Why?
|
| Immunity | 2 | 2022 | 342 | 0.060 |
Why?
|
| G2 Phase | 1 | 2004 | 206 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2004 | 233 | 0.060 |
Why?
|
| Microarray Analysis | 2 | 2014 | 392 | 0.060 |
Why?
|
| Culture Media, Conditioned | 2 | 2001 | 260 | 0.060 |
Why?
|
| Monocytes | 1 | 2007 | 788 | 0.060 |
Why?
|
| Algorithms | 2 | 2013 | 3890 | 0.060 |
Why?
|
| Antigens | 1 | 2004 | 292 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2005 | 1493 | 0.060 |
Why?
|
| Oxygen | 1 | 2007 | 754 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2004 | 383 | 0.060 |
Why?
|
| Agglutinins | 1 | 2022 | 19 | 0.060 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 211 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 577 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 651 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2011 | 342 | 0.060 |
Why?
|
| Keratin-5 | 1 | 2022 | 57 | 0.050 |
Why?
|
| RNA | 3 | 2011 | 1013 | 0.050 |
Why?
|
| MCF-7 Cells | 2 | 2015 | 550 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 621 | 0.050 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 148 | 0.050 |
Why?
|
| Alanine | 1 | 2023 | 240 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2004 | 406 | 0.050 |
Why?
|
| Serine | 1 | 2024 | 388 | 0.050 |
Why?
|
| Genetic Complementation Test | 3 | 1993 | 125 | 0.050 |
Why?
|
| Glycine | 1 | 2004 | 289 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 528 | 0.050 |
Why?
|
| Lymphatic Metastasis | 3 | 2006 | 4844 | 0.050 |
Why?
|
| Immunization | 1 | 2004 | 397 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 456 | 0.050 |
Why?
|
| Biomarkers | 1 | 2014 | 5047 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 4892 | 0.050 |
Why?
|
| Species Specificity | 2 | 2013 | 777 | 0.050 |
Why?
|
| Cyclin B1 | 1 | 2001 | 56 | 0.050 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 359 | 0.050 |
Why?
|
| Cyclin B | 1 | 2001 | 63 | 0.050 |
Why?
|
| Lac Operon | 1 | 2001 | 122 | 0.050 |
Why?
|
| Testis | 1 | 2006 | 717 | 0.050 |
Why?
|
| Endocytosis | 1 | 1982 | 225 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 329 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2001 | 62 | 0.050 |
Why?
|
| Cytogenetics | 1 | 2001 | 149 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2023 | 483 | 0.050 |
Why?
|
| DNA Primers | 3 | 2010 | 1399 | 0.050 |
Why?
|
| Dependovirus | 1 | 2002 | 135 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2021 | 163 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 716 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2016 | 10001 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 598 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 371 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 566 | 0.050 |
Why?
|
| Proteasome Inhibitors | 2 | 2017 | 231 | 0.050 |
Why?
|
| Arginine | 1 | 2004 | 500 | 0.050 |
Why?
|
| Cricetinae | 3 | 1993 | 706 | 0.050 |
Why?
|
| Chloroquine | 1 | 2021 | 53 | 0.050 |
Why?
|
| Collagen | 1 | 2004 | 752 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2022 | 294 | 0.050 |
Why?
|
| Biopsy | 3 | 2017 | 3443 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2007 | 355 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2006 | 997 | 0.050 |
Why?
|
| Fibroblast Growth Factor 6 | 1 | 2000 | 2 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2001 | 62 | 0.050 |
Why?
|
| Progesterone | 1 | 2003 | 513 | 0.050 |
Why?
|
| Chromosomes | 1 | 2001 | 244 | 0.050 |
Why?
|
| Carcinoma, Giant Cell | 1 | 2020 | 9 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2027 | 0.050 |
Why?
|
| Fasting | 1 | 1982 | 349 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 862 | 0.050 |
Why?
|
| Lymphoma | 1 | 2009 | 1467 | 0.050 |
Why?
|
| Enzyme Induction | 2 | 2013 | 249 | 0.050 |
Why?
|
| Testicular Neoplasms | 1 | 2004 | 529 | 0.050 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2020 | 103 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2011 | 844 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2017 | 992 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2013 | 3341 | 0.050 |
Why?
|
| Glucuronic Acid | 1 | 2019 | 15 | 0.050 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2019 | 18 | 0.050 |
Why?
|
| Carcinogens | 1 | 2021 | 384 | 0.050 |
Why?
|
| S-Adenosylmethionine | 1 | 2019 | 43 | 0.050 |
Why?
|
| Estradiol | 1 | 2003 | 748 | 0.050 |
Why?
|
| Adenine | 1 | 2023 | 631 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2013 | 6009 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 1879 | 0.040 |
Why?
|
| Fibroblast Growth Factor 9 | 1 | 1999 | 20 | 0.040 |
Why?
|
| Viral Vaccines | 1 | 2002 | 304 | 0.040 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2019 | 15 | 0.040 |
Why?
|
| Texas | 3 | 2017 | 6311 | 0.040 |
Why?
|
| Jews | 1 | 1999 | 59 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 734 | 0.040 |
Why?
|
| Bradykinin | 1 | 1999 | 79 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1999 | 122 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 241 | 0.040 |
Why?
|
| Reference Values | 1 | 2001 | 1099 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 1993 | 1213 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2002 | 494 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 79 | 0.040 |
Why?
|
| BRCA2 Protein | 2 | 1999 | 358 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2013 | 1216 | 0.040 |
Why?
|
| Thrombospondin 1 | 1 | 1999 | 55 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2023 | 669 | 0.040 |
Why?
|
| Precancerous Conditions | 3 | 2015 | 1058 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2022 | 291 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2018 | 44 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 116 | 0.040 |
Why?
|
| Carboxylesterase | 1 | 2018 | 33 | 0.040 |
Why?
|
| Binding Sites | 3 | 2011 | 2171 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 94 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 342 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2023 | 2063 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 73 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 1998 | 60 | 0.040 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Azacitidine | 2 | 2015 | 1149 | 0.040 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 1998 | 37 | 0.040 |
Why?
|
| Computational Biology | 2 | 2017 | 1271 | 0.040 |
Why?
|
| Atrophy | 2 | 2010 | 261 | 0.040 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2017 | 20 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2015 | 1299 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 1225 | 0.040 |
Why?
|
| Parvovirus B19, Human | 1 | 1997 | 39 | 0.040 |
Why?
|
| Parvoviridae Infections | 1 | 1997 | 38 | 0.040 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2017 | 12 | 0.040 |
Why?
|
| ROC Curve | 2 | 2014 | 1183 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2017 | 32 | 0.040 |
Why?
|
| Second Harmonic Generation Microscopy | 1 | 2016 | 7 | 0.040 |
Why?
|
| Biological Transport | 1 | 2018 | 597 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 368 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2017 | 81 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 245 | 0.040 |
Why?
|
| Prealbumin | 1 | 1997 | 37 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2003 | 1533 | 0.040 |
Why?
|
| Luciferases | 2 | 2011 | 445 | 0.040 |
Why?
|
| AC133 Antigen | 1 | 2016 | 110 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 336 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 1999 | 387 | 0.040 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2017 | 167 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2018 | 235 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2006 | 1062 | 0.040 |
Why?
|
| Tosyl Compounds | 1 | 2016 | 40 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 105 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4557 | 0.040 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 56 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2018 | 242 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2017 | 223 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 109 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 217 | 0.030 |
Why?
|
| Vaccination | 1 | 2002 | 1123 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 188 | 0.030 |
Why?
|
| Metabolomics | 1 | 2019 | 478 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2017 | 287 | 0.030 |
Why?
|
| Mice, Inbred ICR | 2 | 2013 | 239 | 0.030 |
Why?
|
| Mesocricetus | 2 | 1993 | 114 | 0.030 |
Why?
|
| Organ Size | 2 | 2010 | 690 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 203 | 0.030 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2015 | 103 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 769 | 0.030 |
Why?
|
| Metabolome | 1 | 2018 | 344 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6207 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 159 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2022 | 37905 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 300 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2007 | 268 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2020 | 2232 | 0.030 |
Why?
|
| Amyloidosis | 1 | 1997 | 176 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 222 | 0.030 |
Why?
|
| Blood Physiological Phenomena | 1 | 1994 | 8 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 155 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 34 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2015 | 76 | 0.030 |
Why?
|
| Liver X Receptors | 1 | 2014 | 31 | 0.030 |
Why?
|
| RNA, Ribosomal | 1 | 1995 | 83 | 0.030 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2014 | 22 | 0.030 |
Why?
|
| Introns | 3 | 2006 | 432 | 0.030 |
Why?
|
| Cycloheximide | 1 | 1994 | 97 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2021 | 1996 | 0.030 |
Why?
|
| Kallikreins | 1 | 2014 | 84 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 927 | 0.030 |
Why?
|
| G1 Phase | 1 | 2015 | 285 | 0.030 |
Why?
|
| Diarrhea | 1 | 2018 | 686 | 0.030 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1998 | 436 | 0.030 |
Why?
|
| Anoikis | 1 | 2014 | 63 | 0.030 |
Why?
|
| Keratin-14 | 1 | 2013 | 24 | 0.030 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2014 | 107 | 0.030 |
Why?
|
| DNA, Single-Stranded | 1 | 1994 | 106 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2010 | 2307 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 501 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 1999 | 1046 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 41 | 0.030 |
Why?
|
| Anilides | 1 | 2016 | 268 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 475 | 0.030 |
Why?
|
| Receptors, Antigen | 1 | 2013 | 76 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 2013 | 34 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 699 | 0.030 |
Why?
|
| Thymidine | 2 | 2006 | 155 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 1293 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 1993 | 84 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 1283 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 252 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2012 | 7 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 717 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 612 | 0.030 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 14 | 0.030 |
Why?
|
| Starvation | 2 | 1983 | 27 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2012 | 46 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2012 | 47 | 0.030 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 201 | 0.030 |
Why?
|
| Tongue Diseases | 1 | 1992 | 17 | 0.030 |
Why?
|
| Cryptococcosis | 1 | 1993 | 63 | 0.030 |
Why?
|
| Heparin | 1 | 2015 | 360 | 0.030 |
Why?
|
| Nitrites | 1 | 2012 | 61 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 96 | 0.030 |
Why?
|
| Response Elements | 1 | 2013 | 193 | 0.030 |
Why?
|
| Leg Ulcer | 1 | 1992 | 24 | 0.030 |
Why?
|
| Yeasts | 1 | 2012 | 74 | 0.030 |
Why?
|
| Calcitriol | 1 | 2013 | 127 | 0.030 |
Why?
|
| Fibrosarcoma | 1 | 1993 | 135 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 2012 | 149 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 889 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 700 | 0.030 |
Why?
|
| Keratins | 2 | 2004 | 330 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2013 | 334 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 182 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 270 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.030 |
Why?
|
| Axin Protein | 1 | 2012 | 27 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 442 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 467 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2013 | 562 | 0.030 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2011 | 2 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 557 | 0.030 |
Why?
|
| Casein Kinase I | 1 | 2012 | 23 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 253 | 0.030 |
Why?
|
| Ulcer | 1 | 1992 | 78 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1993 | 254 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2013 | 235 | 0.030 |
Why?
|
| Dishevelled Proteins | 1 | 2012 | 59 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 1439 | 0.030 |
Why?
|
| Casein Kinase Ialpha | 1 | 2011 | 16 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2012 | 149 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2012 | 77 | 0.030 |
Why?
|
| Mouth Mucosa | 1 | 1992 | 216 | 0.030 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 80 | 0.030 |
Why?
|
| Temperature | 1 | 1993 | 506 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 675 | 0.030 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 1 | 2011 | 4 | 0.030 |
Why?
|
| Autopsy | 1 | 2011 | 173 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1994 | 731 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2012 | 684 | 0.020 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2011 | 28 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2011 | 32 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 278 | 0.020 |
Why?
|
| Epoxide Hydrolases | 1 | 2011 | 53 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 612 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1994 | 507 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 987 | 0.020 |
Why?
|
| Necrosis | 1 | 1992 | 580 | 0.020 |
Why?
|
| Cardiomyopathies | 1 | 1997 | 610 | 0.020 |
Why?
|
| Glycolysis | 1 | 2013 | 519 | 0.020 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2011 | 81 | 0.020 |
Why?
|
| Bacteria | 2 | 2012 | 611 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 335 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 546 | 0.020 |
Why?
|
| Ribonuclease P | 1 | 2009 | 12 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 931 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2013 | 479 | 0.020 |
Why?
|
| Methotrexate | 1 | 1993 | 999 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 14889 | 0.020 |
Why?
|
| Aspartate-Ammonia Ligase | 1 | 1989 | 21 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1993 | 621 | 0.020 |
Why?
|
| Ligases | 1 | 1989 | 70 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2009 | 110 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1989 | 69 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1997 | 2358 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 942 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2010 | 251 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2012 | 668 | 0.020 |
Why?
|
| Registries | 1 | 2016 | 2170 | 0.020 |
Why?
|
| Meningeal Neoplasms | 1 | 1993 | 441 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2014 | 1353 | 0.020 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2008 | 25 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 483 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 856 | 0.020 |
Why?
|
| Mesothelioma | 1 | 2013 | 544 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 376 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2020 | 2326 | 0.020 |
Why?
|
| Dutasteride | 1 | 2007 | 10 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2007 | 18 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2017 | 32848 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 59 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 4744 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2008 | 111 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 256 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2007 | 101 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1993 | 717 | 0.020 |
Why?
|
| Bias | 1 | 2008 | 205 | 0.020 |
Why?
|
| Dimerization | 1 | 2007 | 304 | 0.020 |
Why?
|
| Risk Factors | 2 | 2016 | 17523 | 0.020 |
Why?
|
| Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein | 1 | 2006 | 24 | 0.020 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2006 | 30 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 980 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2006 | 23 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 2 | 2011 | 4975 | 0.020 |
Why?
|
| Pneumonia | 1 | 1993 | 751 | 0.020 |
Why?
|
| Clone Cells | 1 | 2008 | 555 | 0.020 |
Why?
|
| Bortezomib | 1 | 2008 | 543 | 0.020 |
Why?
|
| Kidney | 2 | 1993 | 2146 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2008 | 324 | 0.020 |
Why?
|
| SOX9 Transcription Factor | 1 | 2007 | 170 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 142 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2006 | 132 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2006 | 27 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2006 | 53 | 0.020 |
Why?
|
| Contraceptive Agents, Male | 1 | 2006 | 20 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 448 | 0.020 |
Why?
|
| Microcomputers | 1 | 2006 | 36 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2006 | 83 | 0.020 |
Why?
|
| Cells | 1 | 2006 | 31 | 0.020 |
Why?
|
| Cell Communication | 1 | 2009 | 509 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 328 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2007 | 269 | 0.020 |
Why?
|
| Skin | 2 | 2004 | 1259 | 0.020 |
Why?
|
| Sarcoma, Kaposi | 1 | 1987 | 187 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2006 | 682 | 0.020 |
Why?
|
| Parotid Neoplasms | 1 | 1986 | 148 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2016 | 12873 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 703 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 358 | 0.020 |
Why?
|
| Glioblastoma | 2 | 2011 | 1797 | 0.020 |
Why?
|
| Seminiferous Tubules | 1 | 2004 | 52 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2009 | 1070 | 0.020 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 2005 | 236 | 0.020 |
Why?
|
| Genistein | 1 | 2004 | 73 | 0.020 |
Why?
|
| Injections, Intradermal | 1 | 2004 | 58 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 248 | 0.020 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2004 | 178 | 0.020 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2004 | 206 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1987 | 1258 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 402 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 31252 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 661 | 0.010 |
Why?
|
| Flutamide | 1 | 2003 | 40 | 0.010 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 205 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 1546 | 0.010 |
Why?
|
| Software | 1 | 2011 | 1321 | 0.010 |
Why?
|
| Sulfones | 1 | 2004 | 143 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2006 | 336 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 826 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 367 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 521 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 289 | 0.010 |
Why?
|
| Tretinoin | 1 | 2006 | 623 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 639 | 0.010 |
Why?
|
| Osteopontin | 1 | 2003 | 148 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1982 | 124 | 0.010 |
Why?
|
| Colchicine | 1 | 1982 | 52 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 589 | 0.010 |
Why?
|
| Calcinosis | 1 | 1986 | 423 | 0.010 |
Why?
|
| Ketone Bodies | 1 | 1982 | 56 | 0.010 |
Why?
|
| United States | 1 | 2019 | 15433 | 0.010 |
Why?
|
| Hepatitis | 1 | 2002 | 93 | 0.010 |
Why?
|
| Perfusion | 1 | 1983 | 293 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2004 | 328 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 414 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 621 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 3569 | 0.010 |
Why?
|
| Adenoma | 1 | 1986 | 716 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 608 | 0.010 |
Why?
|
| Leucine | 1 | 1982 | 352 | 0.010 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 446 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 13310 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 798 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 176 | 0.010 |
Why?
|
| Lysosomes | 1 | 1982 | 347 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 1390 | 0.010 |
Why?
|
| Cadherins | 1 | 2003 | 660 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 7702 | 0.010 |
Why?
|
| Kallidin | 1 | 1999 | 1 | 0.010 |
Why?
|
| Kinins | 1 | 1999 | 2 | 0.010 |
Why?
|
| Receptors, Bradykinin | 1 | 1999 | 4 | 0.010 |
Why?
|
| New York City | 1 | 1999 | 74 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2016 | 16273 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 4314 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1999 | 39 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1999 | 60 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1999 | 227 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2004 | 1620 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 1016 | 0.010 |
Why?
|
| Endothelin-Converting Enzymes | 1 | 1998 | 2 | 0.010 |
Why?
|
| Endothelin-3 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Receptor, Endothelin B | 1 | 1998 | 7 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 1998 | 18 | 0.010 |
Why?
|
| Receptors, Endothelin | 1 | 1998 | 24 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1998 | 44 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1989 | 354 | 0.010 |
Why?
|
| Biological Availability | 1 | 1998 | 214 | 0.010 |
Why?
|
| Europe | 1 | 1999 | 649 | 0.010 |
Why?
|
| Tensins | 1 | 1997 | 3 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 170 | 0.010 |
Why?
|
| Neocortex | 1 | 1998 | 98 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1997 | 111 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 508 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1999 | 974 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 220 | 0.010 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2001 | 840 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1997 | 694 | 0.010 |
Why?
|
| Child | 1 | 2016 | 29154 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1997 | 829 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1995 | 293 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1995 | 154 | 0.010 |
Why?
|
| Point Mutation | 1 | 1997 | 769 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1993 | 27 | 0.010 |
Why?
|
| Psoriasis | 1 | 1993 | 126 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1998 | 1863 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1997 | 1145 | 0.010 |
Why?
|
| Fibroblast Growth Factor 4 | 1 | 1990 | 17 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1997 | 1320 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1993 | 613 | 0.010 |
Why?
|
| Myocardium | 1 | 1997 | 1313 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1989 | 118 | 0.010 |
Why?
|
| Asparagine | 1 | 1989 | 38 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1989 | 264 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1990 | 259 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 5673 | 0.010 |
Why?
|
| Bacteriophages | 1 | 1989 | 71 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 2576 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1989 | 234 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1987 | 36 | 0.000 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 57 | 0.000 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1989 | 317 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 121 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1987 | 362 | 0.000 |
Why?
|
| Cytoplasmic Granules | 1 | 1986 | 89 | 0.000 |
Why?
|
| Organoids | 1 | 1986 | 287 | 0.000 |
Why?
|
| Phenylalanine | 1 | 1982 | 142 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1997 | 4849 | 0.000 |
Why?
|